Skip to main content

Heparin - A Century of Progress

  • Book
  • © 2012

Overview

  • Written by leading experts in the field
  • With numerous illustrations
  • A valuable reference work on the occasion of the upcoming centenary of heparin
  • Includes supplementary material: sn.pub/extras

Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 207)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (19 chapters)

  1. Introduction

  2. Unfractionated and Low-Molecular-Weight Heparins

  3. Unfractionated and Low Molecular Weight Heparins

  4. Clinical Use of Heparin and LMWH

  5. Non-anticoagulant Indications for Heparin and Related Compounds

  6. Non Anticoagulant Indictions for Heparin and Related Compounds

  7. Heparin-like Entities

Keywords

About this book

Heparins remain amongst the most commonly used drugs in clinical practice.  Almost 100 years have passed since the initial discovery of this complex substance and, during this time, understanding of the nature and uses of heparin and related molecules has grown dramatically. The aim of this volume is to summarise the developments that have led to the current status of both heparins as drugs and the field of heparin research, with a focus on the particularly rapid progress that has been made over the past three decades. Individual sections are dedicated to the nature of heparin as a biological molecule, the current approaches and techniques that are used to ensure the safety and reliability of heparin as a medicine, the clinical pharmacology of heparin as an anticoagulant drug, effects and potential applications of heparin aside of those involving haemostasis and, finally, the nature and potential uses of heparin-like materials from both natural and synthetic sources.

Editors and Affiliations

  • School of Pharmacy, University of London, London, United Kingdom

    Rebecca Lever

  • Standards and Control, National Institute for Biological, Potters Bar, Herts., United Kingdom

    Barbara Mulloy

  • King's College London, Sackler Inst. Pulmonary Pharmacology, London, United Kingdom

    Clive P. Page

Bibliographic Information

Publish with us